Alembic Pharmaceuticals Ltd.
Snapshot View

651.50 -6.70 ▼-1.0%

17 August 2022, 09:07:17 AM
Volume: 1,694

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alembicpharmaceuticals.com
Market Cap 12,933.85 Cr.
Enterprise Value(EV) 13,494.41 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 16.04 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 41.02 Trailing Twelve Months Ending 2022-06
Industry PE 32.22 Trailing Twelve Months Ending 2022-06
Book Value / Share 263.47 Trailing Twelve Months Ending 2022-06
Price to Book Value 2.50 Calculated using Price: 658.00
Dividend Yield 1.52 Period Ending 2021-03
No. of Shares Subscribed 19.66 Cr. 196,563,124 Shares
FaceValue 2
Company Profile
The company is principally engaged in the manufacturing and selling of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company presents an extensive range of branded and generic formulations, in compliance with international and national regulations, that cater to diverse therapeutic segments.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.02%
1 Week
-0.21%
1 Month
-7.37%
3 Month
-12.91%
6 Month
-8.84%
1 Year
-15.41%
2 Year
-34.90%
5 Year
+26.37%
10 Year
+936.60%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 36.81 39.97 36.24 58.03 23.25 20.42 24.00 26.97 26.71
Return on Capital Employed (%) 32.05 43.54 37.54 65.87 28.87 22.15 22.66 23.30 26.13
Return on Assets (%) 14.79 18.79 18.76 33.76 14.97 12.25 13.15 14.64 17.56

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 503 676 885 1,597 1,902 2,220 2,719 3,219 5,128 5,238
Non Curr. Liab. 103 94 72 84 94 576 570 1,047 361 162
Curr. Liab. 529 603 684 944 814 1,267 1,664 1,752 1,281 1,717
Minority Int. 0 0 -1 -29 -61
Equity & Liab. 1,135 1,372 1,641 2,626 2,811 4,064 4,952 5,989 6,709 7,116
Non Curr. Assets 416 516 750 917 1,317 2,116 2,820 3,526 4,131 4,337
Curr. Assets 719 857 891 1,708 1,494 1,948 2,132 2,463 2,578 2,779
Misc. Exp. not W/O
Total Assets 1,135 1,372 1,641 2,626 2,811 4,064 4,952 5,989 6,709 7,116

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 1,520 1,863 2,056 3,166 3,135 3,131 3,935 4,606 5,393 5,242
Other Income 17 4 12 9 3 35 27 14 87 15
Total Income 1,537 1,868 2,068 3,175 3,137 3,166 3,962 4,620 5,481 5,257
Total Expenditure -1,272 -1,506 -1,661 -2,161 -2,520 -2,516 -3,079 -3,392 -3,913 -4,554
PBIDT 265 362 407 1,014 617 650 883 1,228 1,568 703
Interest -24 -10 -4 -5 -5 -3 -18 -27 -16 -24
Depreciation -35 -40 -44 -72 -83 -105 -115 -157 -183 -301
Taxation -41 -75 -76 -216 -122 -120 -157 -199 -253 -69
Exceptional Items -44
PAT 165 236 283 720 407 421 593 801 1,115 309
Minority Interest 0 0 1 28 32 19
Share Associate 0 0 -4 -8 -9 0 32 -12
Other Related Items
Consolidated Net Profit 165 236 283 720 403 413 584 829 1,178 315
Adjusted EPS 9 12 15 38 21 22 31 44 60 16

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 142 265 240 172 948 329 312 812 449 1,463
Cash Fr. Inv. -56 -67 -81 -256 -307 -486 -884 -756 -732 -839
Cash Fr. Finan. -45 -229 -151 87 -224 -129 503 59 155 -597
Net Change 41 -31 8 3 417 -286 -69 115 -128 27
Cash & Cash Eqvt 47 16 24 27 439 153 84 199 72 98

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 72.97 69.77 69.78 69.48 69.48 69.48 69.48 69.61 69.61
Public 27.03 30.23 30.22 30.52 30.52 30.52 30.52 30.39 30.39
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 11 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call
Wed, 10 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call
Mon, 08 Aug 2022
Loss of share certificate
Alembic Pharmaceuticals Limited has informed the Exchange about Loss of share certificate for the purpose of claiming those shares from the Investor Education and Protection Fund (IEPF).

Technical Scans View Details >>

Tue, 16 Aug 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months
RSI Bullish RSI Bullish

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,443.18 919.00 +0.5%
Divi's Laboratories Ltd. 99,072.87 3,752.00 +0.5%
Cipla Ltd. 83,487.41 1,039.75 +0.5%
Dr. Reddy's Laboratories Ltd. 71,536.21 4,317.95 +0.5%
Apollo Hospitals Enterprise Ltd. 62,537.70 4,349.00 0.0%
Torrent Pharmaceuticals Ltd. 53,261.16 1,560.00 -0.9%
Piramal Enterprises Ltd. 45,983.34 1,935.00 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.42 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.92 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-06 33.44 1,039.75 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.91 4,317.95 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.76 4,349.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.33 1,560.00 -0.9%
Piramal Enterprises Ltd. Consolidated 2022-06 24.47 1,935.00 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.38 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-06 3.87 1,039.75 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.53 4,317.95 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.52 4,349.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.31 1,560.00 -0.9%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,935.00 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,039.75 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,317.95 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,560.00 -0.9%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,935.00 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,039.75 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,317.95 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,560.00 -0.9%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,935.00 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,039.75 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,317.95 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,560.00 -0.9%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,935.00 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,039.75 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,317.95 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,560.00 -0.9%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,935.00 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,039.75 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,317.95 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,560.00 -0.9%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,935.00 +0.4%

FAQ's On Alembic Pharmaceuticals Ltd.

Can I Buy Alembic Pharma Shares now?

What is the Share Price of Alembic Pharma?

What is the Relative Strength Index (RSI) Value of Alembic Pharma?

What is the Market Capital (MCAP) of Alembic Pharma?

What are the key metrics to analyse Alembic Pharma?

What is the Price Performance of Alembic Pharma?